| Document |
Document Title |
|
WO/2012/058957 |
The present invention concerns polysaccharide extracts of epimedium and, in particular, concerns total polysaccharide extracts of Chinese-medicine medicinal grade leaves of epimedium, acidic polysaccharide fractions and non-polysaccharid...
|
|
WO/2012/060111 |
The purpose of the invention is to provide a glucan containing at least one residue selected from an N-acetylglucosamine residue and a galactose residue, and a modified product thereof. A branched glucan according to the invention is a b...
|
|
WO/2012/060110 |
The purpose of the present invention is to provide a glucosamine-containing glucan, a modified product of the glucosamine-containing glucan and a conjugate of the glucosamine-containing glucan. This glucosamine-containing glucan is a glu...
|
|
WO/2012/060738 |
The invention relates to a novel clathrate complex of β-cyclodextrin with 1-{[6-bromo-1-methyl-5-methoxy-2-phenylthiomethyl-1-H-indole
-3-yl]carbonyl}-4-benzylpiperazine of formula (1), wherein the molar ratio of 1-{[6-bromo-1-methyl-5-...
|
|
WO/2012/054311 |
This disclosure relates generally to cross-linked hyaluronic acid compositions, threads made from such compositions, methods of making such threads and uses thereof, for example, in aesthetic applications (e.g., facial contouring, soft t...
|
|
WO/2012/052874 |
The invention relates to a device for detecting analytes, including a plastic substrate at least partially covered by bonding polymers attached to the substrate in a non-covalent manner, said bonding polymers comprising a polysaccharide ...
|
|
WO/2012/053776 |
The present invention relates to hyaluronic acid compounds, to a method for preparing same and to the use thereof. A soft-tissue filler containing the hyaluronic acid compounds of the present invention has a longer biodegradation rate th...
|
|
WO/2012/046954 |
A method for preparing hyaluronic acid derivative particles by separating a gel-state hyaluronic acid derivative into particles having a uniform size, comprises the following steps: providing a hyaluronic acid derivative in a chamber hou...
|
|
WO/2012/045198 |
Use of polysaccharides from Radix isatidis in the manufacture of medicaments for treating and/or preventing diseases induced by influenza virus and complication thereof, wherein the molecular weight of the polysaccharides from Radix isat...
|
|
WO/2012/042123 |
The invention relates to novel polysaccharides with an antithrombotic activity, having at least one covalent bond with biotin or a biotin derivative, characterised in that said covalent bond is resistant to metabolic cleavage and compris...
|
|
WO/2012/044832 |
Described herein are methods for treating a subject with combinations of polymer-agent particles and cyclodextrin polymer agent conjugates. The methods herein may be used to treat subjects identified with cancer, cardiovascular disorders...
|
|
WO/2012/044263 |
This invention involves the synthesis and fabrication of long lasting fragranced chitosan. The chemical synthesis and structures of chitosan derivatives in various forms, e.g. nano/microspheres, colloidal suspension of nano/microspheres,...
|
|
WO/2012/040592 |
The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relate...
|
|
WO/2012/038238 |
The invention relates to highly concentrated, spherical, biopolymer gel particle suspensions comprising particle of defined particle diameter range (e.g., 1 to 50µ) and process for preparing the suspensions utilizing high internal phase...
|
|
WO/2012/034544 |
The invention relates to the method of preparation of highly substituted hyaluronic acid amides with a controllable degree of substitution, which are prepared in a polar aprotic environment from an acidic form of hyaluronic acid in the p...
|
|
WO/2012/034996 |
The present invention relates to a process for production, on an industrial scale, of L- fucose (or 6-deoxygalactose) from hydrolysis of polysaccharides obtainable by means of aerobic fermentation of a new isolated microbial strain belon...
|
|
WO/2012/034544 |
The invention relates to the method of preparation of highly substituted hyaluronic acid amides with a controllable degree of substitution, which are prepared in a polar aprotic environment from an acidic form of hyaluronic acid in the p...
|
|
WO/2012/036152 |
The present invention provides a high purity heparin useful as a medicine, a cosmetic, a research reagent and the like, and a production method therefor, in more detail, a method for producing heparin, the method comprising mixing a hepa...
|
|
WO/2012/032150 |
0240PTWO 12 PROCESS FOR OBTAINING HYALURONIC ACID OF DEFINED MOLECULAR WEIGHT ABSTRACT A process is described for obtaining, in an innovative, simple and economical manner, hyaluronic acid and hyaluronans at varying molecular weight.
|
|
WO/2012/032153 |
The present invention relates to a method of producing hyaluronic acid (HA) in Escherichia coli and Bacillus megaterium through episomal plasmid vectors wherein the gene is under the control of strong promoter T7, preferably under the co...
|
|
WO/2012/032151 |
Describes cooperative hybrid complexes of hyaluronic acid, a simple and economical method for production thereof and use thereof in the area of medicine, cosmetics and food.
|
|
WO/2012/032154 |
The present invention relates to a method for the production of hyaluronic acid (HA) in Bacillus subtilis and Escherichia coli through plasmid vectors wherein the gene is under the control of strong promoter Pgrac, and a system for the s...
|
|
WO/2012/027834 |
Novel hyaluronic acid-containing biopolymers are provided which exhibit increased hydrophilicity and reduced protein adsorption. In one aspect, the biopolymer incorporates hyaluronic acid modified to include a linking agent in a molar ex...
|
|
WO/2012/030030 |
The present invention relates to a chitosan derivative having a visible-light-curing characteristic whereby it is cured by visible-light irradiation, and to a use for the same as a medical raw material. The chitosan derivative of the pre...
|
|
WO/2012/029863 |
The present invention provides: a biological substance which can enhance the proliferation and differentiation of cells; a method for evaluating the proliferation and differentiation of cells, which targets the biological substance; a co...
|
|
WO/2012/028565 |
There is disclosed a method for the manufacture of a crosslinked superabsorbent polymer material. There is further disclosed a crosslinked superabsorbent polymer material manufactured with the method. Using the new polymer material the p...
|
|
WO/2012/025937 |
A novel process for the preparation of 6-perdeoxy-6-per-halo Gamma cyclodextrin which is a useful intermediate in the synthesis of Sugammadex is disclosed. The process involves the reaction of Gamma cyclodextrin with phosphorous halide i...
|
|
WO/2012/019499 |
Disclosed in the present invention is bis[-6-oxo-(-3-m-nitrobenzene sulfonyl-succinic acid-1,4-monoester-4-)-]-β-cyclodextrin and a preparation process thereof and its use as a chiral selector in high performance liquid chromatography (...
|
|
WO/2012/019500 |
Disclosed in the present invention is bis-[6-oxo-(2-m-carboxylbenzene sulfonyl-succinic acid 1,4-monoester-4)]-β-cyclodextrin, the preparation process thereof and its use in high performance capillary electrophoresis (HPCE) as a chiral ...
|
|
WO/2012/016978 |
The invention relates to a high molecular weight glycolipid characterized by the presence of rhamnose which has anti-inflammatory activity, particularly in inflammation triggered by ischemia and reperfusion. A further aspect of the inven...
|
|
WO/2012/013646 |
Ethylenically unsaturated glycosides of formula (I), wherein Y, Y', m, A, X, R3 and R4 have the meanings given in the description, are pro- duced by reacting an ethylenically unsaturated compound of formula (II), with a polysaccharide co...
|
|
WO/2012/013670 |
The invention relates to a process for providing esters of hyaluronic acid, hyaluronic acid salts or hyaluronic acid derivatives with hydrophobic organic compounds. The process includes the steps of (i) micronizing the hyaluronic acid, s...
|
|
WO/2012/014180 |
The present invention relates to hydrogels based on hyaluronic acid based derivatives, that are more resistant than hyaluronic acid alone towards chemical and enzymatic degradation and are endowed with a mix of chemical and mechanical pr...
|
|
WO/2012/009953 |
Provided are compositions for controlled release of biomolecules, which comprise conjugates of polymers and biomolecules conjugated through non-covalent interactions. Also provided are methods for controlled release of biomolecules and t...
|
|
WO/2012/008722 |
The present invention relates to a filler composition for tissue reinforcement, including hyaluronic acid and alkaline diamine crosslinked hydrogel. The filler composition exhibits the positive physical properties required for tissue rei...
|
|
WO/2012/009315 |
Oligosaccharides from bovine milk, whey and dairy products, and methods of producing bovine milk oligosaccharides are provided.
|
|
WO/2012/008722 |
The present invention relates to a filler composition for tissue reinforcement, including hyaluronic acid and alkaline diamine crosslinked hydrogel. The filler composition exhibits the positive physical properties required for tissue rei...
|
|
WO/2012/008465 |
The present invention provides a (nucleic acid)-polysaccharide complex which can be produced in high yield and has excellent stability and reduced cytotoxicity. That is, the present invention provides a (nucleic acid)-polysaccharide comp...
|
|
WO/2012/009315 |
Oligosaccharides from bovine milk, whey and dairy products, and methods of producing bovine milk oligosaccharides are provided.
|
|
WO/2012/004063 |
Chondroitin is produced by culturing a recombinant microorganism which is obtained by inactivation of a gene encoding an enzyme responsible of fructose residues addition to the linear chondroitin polysaccharide in a microorganism produci...
|
|
WO/2011/160216 |
Provided in the following specification are precursors or synthons that are useful for the synthesis of various arabinose-based chemical and radiochemical derivatives of nitroimidazole-containing azomycin arabinosides, such as radioiodin...
|
|
WO/2011/160216 |
As described herein there is provided novel precursors/synthons, and their chemical and radiochemical derivatives and methods of use thereof.
|
|
WO/2011/158936 |
The purpose is to provide a pullulan-containing powder, which can be produced without resorting to a troublesome purification step using, for example, solvent precipitation and, when shaped into a film, shows a higher breaking strength t...
|
|
WO/2011/157955 |
The invention relates to a chitosan in the form of a micronised powder, to the use thereof to combat certain yeasts, such as Brettanomyces, and to a method for the treatment of a liquid food. In particular, the invention relates to a wat...
|
|
WO/2011/155859 |
The invention relates to bacterial lipopolysaccharide and its components, especially native and chemically modified polysaccharides isolated from Hafnia alvei lipopolysaccharides, as well as conjugates of these polysaccharides with carri...
|
|
WO/2011/155859 |
The invention relates to bacterial lipopolysaccharide and its components, especially native and chemically modified polysaccharides isolated from Hafnia alvei lipopolysaccharides, as well as conjugates of these polysaccharides with carri...
|
|
WO/2011/154803 |
The invention provides a method of enzymatically modifying xylan by selectively removing glucuronic acid and/or arabinose side chains from the xylan with a-D-glucuronidase and/or a-L-arabinofuranosidase, and allowing the modified xylan t...
|
|
WO/2011/156097 |
A coagulant composition includes chitosan, methacryloyloxyethyltrimethyl ammonium methyl sulfate and a redox initiator. A coagulant, method for making the coagulant and clarifying wastewater is also provided.
|
|
WO/2011/155800 |
The present invention relates to a deacetylation hydrolase of a hyaluronic acid, a hyaluronic acid deacetylated by same and a derivative thereof. The deacetylated hyaluronic acid and the derivative thereof of the present invention have t...
|
|
WO/2011/154967 |
A process of fractionation of biomass using aqueous ammonia for fractionation of biomass into lignin, cellulose and/or hemicellulose is provided herein. The process disclosed in the present invention is recovers lignin, cellulose and hem...
|
